Article Text

Download PDFPDF
Nailing the diagnosis: severe nail involvement in adult pulmonary Langerhans cell histiocytosis
  1. Laure Delaval1,2,
  2. Jean-David Bouaziz1,3,
  3. Maxime Battistella1,4,
  4. Gwenaël Lorillon2,
  5. Abdellatif Tazi1,2
  1. 1Université de Paris, UFR de Médecine Paris Nord, Paris, France
  2. 2National Reference Centre for Histiocytoses, Pulmonology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
  3. 3Dermatology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
  4. 4Pathology Department, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
  1. Correspondence to Professor Abdellatif Tazi, Hôpital Saint-Louis, Paris 75475, France; abdellatif.tazi{at}aphp.fr

Statistics from Altmetric.com

Case presentation

A 36-year-old male ex-smoker was referred for the management of pulmonary Langerhans cell histiocytosis (LCH) confirmed by surgical biopsy (figure 1A). He had been treated with desmopressin for 5 years for diabetes insipidus. One year before admission, dyspnoea on exertion had appeared. At the same time, the patient developed painful nail abnormalities on all 10 fingers with subungual hyperkeratosis, purpuric striae, paronychial erythema, longitudinal grooving, splinter haemorrhages, onycholysis, lunula deformation (figure 1B), with no underlying bone involvement on hand X-ray examination. Nail samples were negative for bacteria and fungi. Maculopapular and crusted lesions in the axillary fold, the scalp and the external auditory canal were also present. A nail biopsy showed hyperplastic epidermis, surmounted by thick parakeratosis. The upper dermis was infiltrated by pale histiocytes with eosinophilic cytoplasm and reniform nuclei that positively stained for CD1a antigen, …

View Full Text

Footnotes

  • Contributors LD, J-DB, GL and AT managed the patient. MB analysed and interpreted histological findings. All authors contributed to writing the manuscript. All authors have approved the version of the manuscript submitted for publication.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.